Residency · Residency · Vascular Surgery

Connective Tissue Disorders and the Vascular System

Introduction

Heritable connective tissue disorders (CTDs) impact the structural proteins within the arterial wall, making patients susceptible to aneurysm formation, arterial dissection, and spontaneous rupture. These disorders pose significant challenges for vascular surgeons because the arterial walls are fragile, complicating both open and endovascular repairs. Early recognition, accurate genetic diagnosis, and customized surgical strategies are crucial to improving patient outcomes in this population.

Marfan Syndrome

Genetics and Pathophysiology

Marfan syndrome results from an autosomal dominant mutation in the FBN1 gene, which encodes fibrillin-1. Fibrillin-1 is a vital component of extracellular microfibrils, and its deficiency leads to dysregulated transforming growth factor-beta (TGF-beta) signaling. The syndrome affects approximately 1 in 5,000 individuals. Diagnosis relies on the revised Ghent nosology established in 2010, which combines clinical features such as aortic root dilation, ectopia lentis, and a systemic score with genetic testing.

Vascular Manifestations

The most dangerous vascular manifestation of Marfan syndrome is aortic root dilation and aneurysm, characterized by progressive enlargement of the sinuses of Valsalva. Aortic dissection, particularly type A involving the ascending aorta, is a life-threatening emergency commonly seen in these patients. Mitral valve prolapse is also frequent but generally not life-threatening. Other features include dural ectasia in the lumbosacral region. The risk of dissection correlates with the diameter of the aortic root, the rate at which it grows, and family history.

Surveillance and Management

Patients with Marfan syndrome require annual echocardiography, or more frequent imaging if the aortic root is enlarging, to monitor the diameter of the aortic root. Beta-blocker therapy is the first-line medical treatment, as it reduces the rate of aortic root dilation. Losartan, an angiotensin receptor blocker (ARB) that antagonizes TGF-beta signaling, is used as an adjunct or alternative to beta-blockers. Prophylactic aortic root replacement is recommended when the root diameter reaches 5.0 cm, or earlier at 4.5 cm if there is a family history of dissection, rapid growth exceeding 0.5 cm per year, or significant aortic regurgitation. When feasible, valve-sparing root replacement (David procedure) is preferred over composite valve graft replacement (Bentall procedure). Lifelong imaging surveillance of the entire aorta is necessary after root repair, as distal aortic events occur in 20-30% of Marfan patients.

Loeys-Dietz Syndrome

Genetics

Loeys-Dietz syndrome (LDS) is caused by autosomal dominant mutations in genes encoding TGF-beta receptor subunits (TGFBR1, TGFBR2) or ligands (TGFB2, TGFB3, SMAD3). There are five subtypes (LDS types 1-5), classified based on the specific gene affected.

Clinical Features

LDS is characterized by aggressive arterial disease, with aortic aneurysms and dissections occurring at smaller diameters and younger ages compared to Marfan syndrome. The characteristic clinical triad includes hypertelorism (widely spaced eyes), bifid uvula or cleft palate, and arterial tortuosity with aneurysms. Aneurysms may develop throughout the arterial tree, not limited to the aorta. Cervical spine instability is also a common feature.

Vascular Management

Because of the aggressive nature of arterial disease in LDS, prophylactic aortic root replacement is recommended earlier, typically when the root diameter reaches 4.0 to 4.2 cm, or even smaller depending on the subtype and family history. Surveillance involves aggressive imaging of the entire arterial tree with annual head-to-pelvis computed tomography angiography (CTA) or magnetic resonance angiography (MRA). Medical management includes beta-blockers and losartan. Surgical repair is challenging due to tissue fragility, necessitating meticulous technique with pledgeted sutures and reinforced anastomoses.

Vascular Ehlers-Danlos Syndrome (vEDS, Type IV)

Genetics and Pathophysiology

Vascular Ehlers-Danlos syndrome (vEDS) is caused by an autosomal dominant mutation in the COL3A1 gene, which encodes type III procollagen. Type III collagen is a major structural component of the arterial wall, bowel, and uterus. The prevalence of vEDS ranges from 1 in 50,000 to 1 in 200,000 individuals.

Clinical Features

vEDS is distinguished by arterial rupture without preceding aneurysm formation; arteries may dissect or rupture even when their caliber is normal. Other clinical manifestations include bowel perforation, most commonly of the sigmoid colon, and uterine rupture during pregnancy. Patients often have thin, translucent skin, easy bruising, and characteristic facial features such as thin lips, a small chin, and prominent eyes. The median survival is approximately 50 years.

Vascular Implications

vEDS represents the most dangerous connective tissue disorder for vascular surgeons because the tissue is extremely fragile and sutures tend to tear through the arterial wall. Arterial catheterization and angiography carry significant risks of dissection, perforation, and hemorrhage. Elective surgery should be avoided whenever possible, with non-operative management preferred. When surgery is necessary, pledgeted sutures should be used, tissue handling minimized, and unnecessary clamping avoided. Celiprolol, a beta-blocker with beta-2 agonist properties, has been shown in a randomized trial to reduce cardiovascular events in vEDS patients.

Surgical Principles in vEDS

Surgical strategies include using extra-anatomic bypass routes to avoid operating on fragile native arteries and ligating rather than repairing vessels when possible. Endovascular interventions carry risks but may be preferable to open surgery in cases of acute hemorrhage. Genetic counseling is essential due to the 50% transmission risk to offspring.

Other Connective Tissue Disorders

Turner Syndrome

Turner syndrome, characterized by a 45,X karyotype affecting females, is associated with cardiovascular abnormalities including bicuspid aortic valve in 30% of cases, coarctation of the aorta in 10%, and aortic dilation and dissection. The risk of aortic dissection is increased, and surveillance should use size-indexed aortic dimensions.

Familial Thoracic Aortic Aneurysm and Dissection (FTAAD)

FTAAD is an autosomal dominant condition with variable penetrance involving genes such as ACTA2, MYH11, MYLK, PRKG1, among others. It accounts for approximately 20% of thoracic aortic aneurysms. Genetic testing is recommended for patients with thoracic aortic disease presenting before age 60, those with a family history, or those exhibiting syndromic features.

Fibromuscular Dysplasia (FMD)

Fibromuscular dysplasia is a non-atherosclerotic, non-inflammatory arterial disease predominantly affecting young to middle-aged women. It most commonly involves the renal arteries, followed by the carotid and vertebral arteries. Angiography typically reveals a classic "string of beads" appearance due to medial fibroplasia. FMD is associated with arterial dissection, aneurysms, and renovascular hypertension.

General Principles for Vascular Surgery in CTDs

Genetic testing and counseling should be offered to all patients suspected of having heritable aortopathy, with mandatory family screening of first-degree relatives. Lifelong imaging surveillance of the entire arterial tree, not just the aorta, is essential. Medical therapy aims to reduce hemodynamic stress using beta-blockers and ARBs. Patients should avoid isometric exercise and contact sports. Pregnancy management requires collaboration with maternal-fetal medicine specialists, as pregnancy is extremely high risk in vEDS and carries significant risk in Marfan and Loeys-Dietz syndromes. Surgical techniques must emphasize gentle tissue handling, use of pledgeted sutures, avoidance of excessive tension, and reinforcement of anastomoses.

Key Clinical Pearls

Marfan syndrome, Loeys-Dietz syndrome, and vascular Ehlers-Danlos syndrome are the three most critical connective tissue disorders for vascular surgeons to recognize. Loeys-Dietz syndrome demands earlier prophylactic intervention than Marfan syndrome due to its more aggressive arterial disease. Vascular Ehlers-Danlos syndrome is the most dangerous CTD because tissue fragility renders all vascular interventions high-risk, and elective procedures should be avoided whenever possible. First-degree relatives of patients with heritable aortopathy must undergo imaging screening and be offered genetic testing. Every aortic surgical center should maintain a multidisciplinary aortopathy clinic that integrates genetics, cardiology, and vascular surgery to optimize patient care.

References

1. Loeys BL, Dietz HC, et al. "The revised Ghent nosology for the Marfan syndrome." J Med Genet. 2010;47(7):476-485.
2. Defined, Defined, et al. "Loeys-Dietz syndrome: genetics, clinical features, and management." Eur Heart J. 2017;38(45):3358-3363.
3. Ong KT, Perdu J, et al. "Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome." Lancet. 2010;376(9751):1476-1484.
4. Defined, Defined, et al. "Heritable thoracic aortic disease: genetic basis and clinical management." Circulation. 2017;135(17):e875-e892.

Read this lecture as Markdown